95-14505. Findings of Scientific Misconduct

[Federal Register Volume 60, Number 114 (Wednesday, June 14, 1995)]
[Notices]
[Page 31312]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-14505]



-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary


Findings of Scientific Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the Office of Research Integrity 
(ORI) has made final findings of scientific misconduct in the following 
case:
    Barbara Jones, St. Mary's Hospital, Montreal: The Office of 
Research Integrity (ORI) conducted an investigation into possible 
scientific misconduct on the part of Ms. Barbara Jones while a data 
coordinator at St. Mary's Hospital, Montreal, Quebec. ORI concluded 
that Ms. Jones committed scientific misconduct by falsifying and 
fabricating the dates of tests or examinations required prior to study 
entry for two women entered on the Breast Cancer Prevention Trial 
(BCPT). The BCPT is coordinated by the National Surgical Adjuvant 
Breast and Bowel Project (NSABP) and supported by the National Cancer 
Institute and the National Heart, Lung, and Blood Institute. Because 
the BCPT is still in progress, no conclusions or results have been 
published and no clinical recommendations have been based on the 
results of the study.
    Ms. Jones did not contest the ORI findings or administrative 
actions which require that, for a period of three years, any 
institution which proposes Ms. Jones' participation in PHS-supported 
research must submit a supervisory plan designed to ensure the 
scientific integrity of her contribution. Ms. Jones is also prohibited 
from serving in any advisory capacity to the PHS for a period of three 
years.

FOR FURTHER INFORMATION, CONTACT: Director, Division of Research 
Investigations, Office of Research Integrity, 301-443-5330.
Lyle W. Bivens,
Director, Office of Research Integrity.
[FR Doc. 95-14505 Filed 6-13-95; 8:45 am]
BILLING CODE 4160-17-M